Company intelligence / Profile preview

Althaia

São Paulo, São Paulo, Brazilalthaia.cat ↗

Ownership: Private
Employees: ~474
Development stage: Phase 3

Overview

Althaia is a Brazilian pharmaceutical and biotech company founded in 2010 that develops and manufactures generic drugs and nutraceutical products for the healthcare market. The company is active in drug development, registration, and manufacturing.

Modalities: Small moleculeNutraceutical
Industry: Biotech

Drug pipeline

1 asset

albumin

Phase 3

Indications: Alzheimer's disease

Beyond the preview

Go deeper on Althaia.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Althaia.

Explore the full profile